Market Overview:
Altretamine (CAS 645-05-6) is a chemotherapy agent used to treat ovarian cancer. It is also being studied for the treatment of other types of cancer. Altretamine is available as a capsule, tablet, and enteric coated tablet. The global altretamine market was valued at US$ XX million in 2017 and is projected to reach US$ XX million by 2030, at a CAGR of XX% during the forecast period 2018-2030. The altretamine market can be segmented on the basis of type into capsules, tablets, and enteric coated tablets. On the basis of application, the market can be segmented into hospital pharmacies, retail pharmacies, online pharmacies.
 Industry Outlook.svg)
Product Definition:
Altretamine (CAS 645-05-6) is a cytotoxic agent that belongs to the class of alkylating agents. It is used for the treatment of ovarian cancer.
Capsule:
Capsule is a small package containing medicine substance. It protects drug from getting contaminated and allows it to remain stable during transit. Capsules are usually gelatin or plastic-based shells filled with dry powder or liquid drug. The size of capsule depends on the type of dosage form; for instance, oral capsules are used for tablets while injectable capsules contain drugs in solution form.
Tablet:
Tablet is a form of solid dosage formulation commonly used for the oral administration of drugs. It consists of a non-reactive outer shell, which contains the drug in an inner matrix. The tablet can be disintegrated by means of water, saliva or stomach acid and hence are known as disintegrating tablets or effervescent tablets.
The advantages associated with this formulation include wide acceptance among patients owing to its taste masking properties.
Application Insights:
The general hospitals segment dominated the global market in 2017. This can be attributed to the growing geriatric population and rising number of cancer cases across the globe. Retinoids such as altretamine are used for treatment of skin related disorders including psoriasis, keratinization disorder, and acne among others. Thus, increasing demand for these drugs from general hospitals is expected to drive growth during forecast years.
The online pharmacies segment is anticipated to exhibit lucrative growth over the forecast period owing to easy availability of products at low prices via internet without visiting a pharmacy or medical storeroom personally.com/.us/.
Regional Analysis:
North America accounted for the largest share of global market in 2017. The region is expected to maintain its lead over the forecast period owing to increasing R&D activities and high adoption of technologically advanced pharmaceutical products. In addition, presence of key players with extensive distribution networks is also expected to drive growth in this region.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period due to rising healthcare expenditure and improving healthcare infrastructure in emerging countries such as China, India, Thailand & South Korea. Furthermore, growing awareness regarding cancer treatment options and availability of Altretamine are some factors that can be attributed for rapid regional expansion over past few years - which has been followed by stringent regulatory framework pertaining change in drug approval/performance characteristics or safety profile after marketing (DRP). This has led major companies including Shire US LLC; Takeda Pharmaceuticals North America Inc.; Pfizer Inc.; Merck & Co., Inc.
Growth Factors:
- Increasing incidence of ovarian cancer: The incidence of ovarian cancer is increasing globally. This will drive the demand for altretamine in the coming years.
- Growing awareness about altretamine: There is growing awareness about the benefits of altretamine among patients and healthcare professionals alike. This is likely to boost demand for the drug in the coming years.
- Rising number of clinical trials: A large number of clinical trials are being conducted on altretamine across the globe, which is indicative of its potential as a treatment option for ovarian cancer patients. This will fuel growth in the global Altretamine (CAS 645-05-6) market in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Altretamine (CAS 645-05-6) Market Research Report
By Type
Capsule, Tablet, Enteric Coated Tablet
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Maoxiang Phrama, Zhongfu Phrama, Angsheng Pharma, Chiatai Pharma, Lisheng Pharma, Actiza, Natco Pharma, Eisai
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Altretamine (CAS 645-05-6) Market Report Segments:
The global Altretamine (CAS 645-05-6) market is segmented on the basis of:
Types
Capsule, Tablet, Enteric Coated Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Maoxiang Phrama
- Zhongfu Phrama
- Angsheng Pharma
- Chiatai Pharma
- Lisheng Pharma
- Actiza
- Natco Pharma
- Eisai
 Market Overview.svg)
Highlights of The Altretamine (CAS 645-05-6) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Capsule
- Tablet
- Enteric Coated Tablet
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Altretamine (CAS 645-05-6) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Altretamine is a chemotherapy drug used to treat cancer. It works by killing cancer cells.
Some of the major players in the altretamine (cas 645-05-6) market are Maoxiang Phrama, Zhongfu Phrama, Angsheng Pharma, Chiatai Pharma, Lisheng Pharma, Actiza, Natco Pharma, Eisai.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Altretamine (CAS 645-05-6) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Altretamine (CAS 645-05-6) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Altretamine (CAS 645-05-6) Market - Supply Chain
4.5. Global Altretamine (CAS 645-05-6) Market Forecast
4.5.1. Altretamine (CAS 645-05-6) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Altretamine (CAS 645-05-6) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Altretamine (CAS 645-05-6) Market Absolute $ Opportunity
5. Global Altretamine (CAS 645-05-6) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Type
5.3.1. Capsule
5.3.2. Tablet
5.3.3. Enteric Coated Tablet
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Altretamine (CAS 645-05-6) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Altretamine (CAS 645-05-6) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Altretamine (CAS 645-05-6) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Altretamine (CAS 645-05-6) Demand Share Forecast, 2019-2026
9. North America Altretamine (CAS 645-05-6) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Type
9.7.1. Capsule
9.7.2. Tablet
9.7.3. Enteric Coated Tablet
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Altretamine (CAS 645-05-6) Demand Share Forecast, 2019-2026
10. Latin America Altretamine (CAS 645-05-6) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Type
10.7.1. Capsule
10.7.2. Tablet
10.7.3. Enteric Coated Tablet
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Altretamine (CAS 645-05-6) Demand Share Forecast, 2019-2026
11. Europe Altretamine (CAS 645-05-6) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Type
11.7.1. Capsule
11.7.2. Tablet
11.7.3. Enteric Coated Tablet
11.8. Basi Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Altretamine (CAS 645-05-6) Demand Share, 2019-2026
12. Asia Pacific Altretamine (CAS 645-05-6) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Type
12.7.1. Capsule
12.7.2. Tablet
12.7.3. Enteric Coated Tablet
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Altretamine (CAS 645-05-6) Demand Share, 2019-2026
13. Middle East & Africa Altretamine (CAS 645-05-6) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Altretamine (CAS 645-05-6) Market Size and Volume Forecast by Type
13.7.1. Capsule
13.7.2. Tablet
13.7.3. Enteric Coated Tablet
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Altretamine (CAS 645-05-6) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Altretamine (CAS 645-05-6) Market: Market Share Analysis
14.2. Altretamine (CAS 645-05-6) Distributors and Customers
14.3. Altretamine (CAS 645-05-6) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Maoxiang Phrama
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zhongfu Phrama
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Angsheng Pharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Chiatai Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Lisheng Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Actiza
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Natco Pharma
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Eisai
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
